Kathryn E. Falberg
Director, Halozyme Therapeutics.
Companies
- Nuvation Bio Inc.Board member Feb 12, 2021 to now1
- Arcus BiosciencesBoard member Mar 14, 2018 to now2
- Trade DeskBoard member Sep 20, 2016 to now3
- TricidaBoard member Jun 27, 2018 to Jun 16, 20224
- UroGen Pharma Ltd.Board member Jan 10, 2019 to Jun 9, 20215
- Aimmune Therapeutics (United Kingdom)Board member Aug 5, 2015 to Oct 14, 20206
- Sio Gene Therapies Inc.Board member Apr 11, 2017 to May 16, 20177
- MedivationBoard member Feb 4, 2013 to Sep 30, 20168
- BioMarin PharmaceuticalBoard member Jul 19, 2016 to Sep 1, 20169
- aTyr PharmaBoard member May 6, 2015 to May 26, 201610
- Halozyme TherapeuticsBoard member May 17, 2007 to May 6, 201611
- Jazz PharmaceuticalsChief financial officer Dec 9, 2009 to Mar 6, 201412
- Oruka Therapeutics, Inc.Chief financial officer Mar 3, 2009 to Jun 26, 200913
- Oruka Therapeutics, Inc.Chief operating officer Mar 3, 2009 to Jun 26, 200913
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARNuvation Bio Inc., Board member
- 2SEC EDGARArcus Biosciences, Board member
- 3SEC EDGARTrade Desk, Board member
- 4SEC EDGARTricida, Board member
- 5SEC EDGARUroGen Pharma Ltd., Board member
- 6
- 7
- 8SEC EDGARMedivation, Board member
- 9
- 10SEC EDGARaTyr Pharma, Board member
- 11SEC EDGARHalozyme Therapeutics, Board member
- 12
- 13